Filing Impact
Filing Sentiment
Form Type
6-K
Analyzing...
Organigram Global Inc
Dec 31, 2025
Organigram Extends Innovation Investment with Phylos
216.48M
94.36M
32.26%
6.05%
3.98%
Drug Manufacturers - Specialty & Generic
Healthcare
Canada
Toronto